Owing to the close association of ANOS1 expression with aggressive features and metastatic properties in advanced GC, we further examined the differential expression of ANOS1 between primary lesions and the corresponding lymph node metastases in patients with advanced GC. The gene discussed is ANOS1; the disease is gastric cancer.